Health System Specialty Pharmacists Elevate Care Across Clinical Spaces
Drug Topics
APRIL 30, 2024
The expertise of health system specialty pharmacists, combined with better adherence and better affordability, leads to better patient outcomes.
Tue.Apr 30, 2024
201 
Identifying Food Allergies vs Food Intolerances: Pharmacists Can Play a Critical Role in Education
Pharmacy Times
APRIL 30, 2024
Pharmacists can help patients distinguish between food allergies and intolerances, as well as facilitate access to life-saving medications and preventative care.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Health System Specialty Pharmacies' Role in Cost Reduction
Drug Topics
APRIL 30, 2024
From medication adherence to patient counseling, clinical pharmacists at health system specialty pharmacies can play a role in reducing health care costs.
What we’re starting to learn about H5N1 in cows, and the risk to people
STAT
APRIL 30, 2024
The H5N1 bird flu virus has been around for decades, and the damage it wreaks on chickens and other poultry is well documented. But the recent discovery that the virus has jumped into dairy cattle — whose udders seem to be where the virus either infects or migrates to — has dumbfounded scientists and agricultural authorities. Questions for which there are pretty clear answers when it comes to birds are suddenly unsettled science in cows.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
The Pipeline Is Full of Expensive, Innovative Therapies
Drug Topics
APRIL 30, 2024
Paying for these new therapies, that may be curative for patients, remains a challenge.
Walmart shuttering all 51 health centers, citing lack of profitability
Fierce Healthcare
APRIL 30, 2024
This is a developing story and will be updated with more information. | Walmart is shuttering all 51 health centers along with its virtual care services, the retail giant announced Tuesday morning.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Hospitals no longer required to report COVID-19 data to CDC
Fierce Healthcare
APRIL 30, 2024
Hospitals are off the hook for data reporting requirements that have been in place since the early COVID-19 pandemic. | Hospitals were required to share COVID-19 admissions, ICU capacity and other related data on a daily basis during the height of the COVID-19 pandemic, then the reporting frequency shifted. The CDC said it still encourages hospitals to report their data on a "voluntary" basis and will soon begin displaying those data online.
With younger women getting breast cancer, national panel lowers mammogram screening age to 40
STAT
APRIL 30, 2024
A national advisory panel significantly lowered the age recommendations for screening mammography on Tuesday, saying that all women should start breast cancer screening at age 40, rather than 50, and continue every other year until age 74. The previous recommendations from the panel, the United States Preventive Services Task Force, suggested that women make an individual choice on getting mammography from ages 40 to 49.
Retail Community Pharmacist Wages Declined from 2012 to 2022
Drug Topics
APRIL 30, 2024
Researchers addressed the wage gaps in specific pharmacy settings in relation to big chain retail pharmacy mergers.
STAT+: In a big reversal, Walmart to shut down medical clinics and online care
STAT
APRIL 30, 2024
Walmart had grand ambitions , back in 2019, to grow a network of cheaper primary care clinics attached to its ubiquitous stores. Those ambitions are now dead. The retail giant said Tuesday it is shuttering its 51 medical clinics across five states, as well as its virtual care offering. Walmart attributed the decision to low payments from health insurers and high costs to operate the clinics.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
FDA Grants Full Approval to Tisotumab Vedotin-tftv for Recurrent, Metastatic Cervical Cancer
Pharmacy Times
APRIL 30, 2024
Tisotumab vedotin-tftv is the first antibody-drug conjugate to demonstrate positive overall survival data in patients with previously treated recurrent or metastatic cancer.
CVS scoops up tech-enabled Medicare Advantage broker Hella Health
Fierce Healthcare
APRIL 30, 2024
CVS has quietly acquired Hella Health, a startup Medicare Advantage broker based in New York City, according to a post on LinkedIn. | CVS has quietly acquired Hella Health, a startup Medicare Advantage broker based in New York City, according to a post on LinkedIn.
Women Lead Vaccine Development Across the Industry
Pharmacy Times
APRIL 30, 2024
Notable contributions from female leaders in the pharmaceutical industry demonstrate the exceptional competence of women in vaccine innovation.
Backers of menthol cigarette ban vow to keep up the fight, but concede it will be a long battle
STAT
APRIL 30, 2024
WASHINGTON — Advocates of a federal ban on menthol cigarettes have spent the better part of the last decade trying everything — from federal lawsuits to holding mock funerals outside the White House — to convince Washington policymakers to remove the minty substance from cigarettes. Now, it seems, advocates may just have to sit around and wait.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Key Barriers in Implementing Guideline-Directed Cholesterol Treatment
Pharmacy Times
APRIL 30, 2024
Clinical pharmacists discuss how to address key barriers that get in the way of implementing guideline-directed cholesterol treatment.
FTC targets Novo's Ozempic, others in crackdown on 300-plus 'junk' patent listings in FDA database
Fierce Pharma
APRIL 30, 2024
The U.S. Federal Trade Commission (FTC) is not done with its crackdown on what it views as improper listing of patents with the FDA. | The U.S. FTC is not done with its crackdown on what it views as improper listing of patents in the FDA Orange Book. After an initial round of challenge launched in November against more than 100 patents, the FTC is back targeting another 300-plus patent listings by eight pharma firms.
DEA will move to reclassify marijuana in a historic shift, AP sources say
STAT
APRIL 30, 2024
WASHINGTON — The U.S. Drug Enforcement Administration will move to reclassify marijuana as a less dangerous drug, The Associated Press has learned, a historic shift to generations of American drug policy that could have wide ripple effects across the country. The DEA’s proposal, which still must be reviewed by the White House Office of Management and Budget, would recognize the medical uses of cannabis and acknowledge it has less potential for abuse th
Bristol Myers, Johnson & Johnson plot appeal after US judge dismisses IRA lawsuits
Fierce Pharma
APRIL 30, 2024
Biopharma companies and industry lobbying groups are striking out in their legal efforts to challenge price-cutting measures in the Inflation Reduction Act. | A federal judge tossed lawsuits by Bristol Myers Squibb and Johnson & Johnson, which questioned the constitutionality of the U.S. government requiring drugmakers to negotiate with Medicare on drug pricing.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Opinion: Protect the health of pregnant people and their children by including them in research
STAT
APRIL 30, 2024
Imagine having to make this decision: Your health care provider recommends that you take a specific medicine for an illness or condition but then tells you it hasn’t been tested in people like you. Do you take the medication, or refuse it? That’s the position the 3.5 million women who give birth each year in the U.S. are in when being counseled about taking medicines.
UnitedHealth CEO Witty is set to go before Congress this week. Here's a look at his testimony
Fierce Healthcare
APRIL 30, 2024
UnitedHealth Group CEO Andrew Witty is set to go before two congressional panels on Wednesday to answer lawmaker's questions about the cyberattack on Change Healthcare that caused widespread disrup | UnitedHealth Group CEO Andrew Witty is set to go before two congressional panels on Wednesday to answer lawmakers' questions about the cyberattack on Change Healthcare that caused widespread disruption across healthcare.
STAT+: Eli Lilly raises earnings guidance as Zepbound sales beat expectations
STAT
APRIL 30, 2024
Eli Lilly raised its full-year guidance on Tuesday while it reported strong first-quarter sales of Zepbound, even as the pharmaceutical company struggles to make enough of the obesity drug to meet the enormous demand. Lilly increased its adjusted earnings guidance for 2024 to a range of $13.50 to $14.00 per share, up from a prior forecast of $12.20 to $12.70 per share.
Embracing new delivery models in the UK
pharmaphorum
APRIL 30, 2024
Learn about the exciting developments in healthcare delivery in the UK, including the IDX2 trial, NHS initiatives, NIHR research, and the Digital Delivery Team. Explore how these new delivery models are revolutionising healthcare.
ChatGPT Successful in Providing Medication Therapy Management Services
Drug Topics
APRIL 30, 2024
Researchers aimed to evaluate the efficacy of the OpenAI technology and offer guidance into its future implementation within health care services.
Walmart retreats from healthcare, closing clinics across US
pharmaphorum
APRIL 30, 2024
For the last few years, Walmart has been promising to disrupt the US healthcare sector with a national network of clinics providing low-cost care and telehealth services. Now, it is reining back on those plans.
Opinion: The medical loss ratio has become a barrier to preventive care
STAT
APRIL 30, 2024
Health care regulations in the United States were not designed to keep Americans healthy. The best example of this is what’s known as the medical loss ratio (MLR). This federal requirement establishes how much a health plan can spend on non-medical related items. The goal was to ensure that insurance dollars are being spent on health care, not administrative costs.
Eli Lilly’s growth drivers, Verzenio and Jardiance, suffer clinical setbacks
Fierce Pharma
APRIL 30, 2024
Besides the diabetes and obesity duo of Mounjaro and Zepbound, the SGLT2 inhibitor Jardiance and the CDK4/6 cancer drug Verzenio were cited as the main growth drivers for Eli Lilly’s first quarter. | Besides the diabetes and obesity duo of Mounjaro and Zepbound, the SGLT2 inhibitor Jardiance and the CDK4/6 cancer drug Verzenio were cited as the main growth drivers for Eli Lilly’s first quarter.
California to sell state-branded Narcan generic to cut costs
pharmaphorum
APRIL 30, 2024
California will start selling its own generic of overdose reversal agent naloxone in another example of the use of government-level purchasing power to reduce drug prices
Pemgarda Granted EUA to Prevent COVID-19, Now Available in US
Drug Topics
APRIL 30, 2024
Pemivibart will act as an additional preventive option for COVID-19 among moderately-to-severely immunocompromised adult and adolescent patients, who are disproportionally impacted by the condition.
Lilly cranks up outlook, banking on GLP-1 production expansions despite continuing supply squeeze
Fierce Pharma
APRIL 30, 2024
While an ongoing production expansion push for Eli Lilly's popular tirezeptide-based medicines Mounjaro and Zepbound should help out with perpetual supply strains later this year, the expected | While Eli Lilly's supply for Mounjaro and Zepbound is scheduled to increase during the second half of the year, demand is still expected to outpace supply through 2024 and possibly into 2025, executives said.
Navigating Ethical, Financial Considerations When Delivering Cancer Care
Drug Topics
APRIL 30, 2024
“I think in those situations where you can use the lower cost of the drug, you should, because it's going to help the overall societal perspective. That begins to break down, though, when that low-cost drug is the one that you're losing money on,” said Scott Soefje in a Q&A on balancing cost and margin at a site of care.
FDA wants to hear your thoughts on advisory committees
STAT
APRIL 30, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hello, I’m up bright and early today to report on earnings, with the help of some coffee (with pasteurized milk) and the soundtrack for the new Challengers movie.
Slideshow: COVID-19 Vaccines, Booster Immunity and Emerging Variants
Drug Topics
APRIL 30, 2024
Recent research on COVID-19 vaccination shows that vaccines help fight variants, led to lower cases among children in California, and that boosters provide longer lasting protection.
STAT+: ‘Skinny labels’ on generic medicines saved Medicare $15 billion over a recent six-year period
STAT
APRIL 30, 2024
A controversial provision of a federal law designed to speed copycat drugs to market and foster competition saved Medicare Part D nearly $15 billion from 2015 to 2021 on just 15 medicines during that period, according to a new analysis. The provision is known as skinny labeling, which refers to a move by a company that seeks regulatory approval to market a generic or biosimilar medicine for a specific use, but not for other patented uses for which the brand-name drug is prescribed.
Let's personalize your content